We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CAT Strategic Metals Corporation | CSE:CAT | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.005 | 0.005 | 0.01 | 0.005 | 0.005 | 0.005 | 50,000 | 01:00:00 |
RNS Number:6947H Merrill Lynch International 19 February 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM Merrill Lynch International Date of disclosure 19 February 2003 Date of dealing 18 February 2003 Telephone number 020 7996 1038 Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: 18 February 2003 Cambridge Antibody Tech Group - Common Oxford Glycosciences Plc - Common AMENDMENT state which element(s) of disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price. For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel. No: 0171 638 0129 FORM 38.5 Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in Oxford Glycosciences Plc Class of security Common Date of disclosure 19 February 2003 Date of dealing 18 February 2003 Name of EMM Merrill Lynch International Name of offeree/offeror with whom connected Cambridge Antibody Tech Group Number of securities purchased 5,291 Highest price paid* GBP 1.96 Lowest price paid* GBP 1.90 Number of securities sold 13,975 Highest price paid* GBP 2.00 Lowest price paid* GBP 2.00 *Currency must be stated FORM 38.5 Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in Cambridge Antibody Tech Group Class of security Common Date of disclosure 19 February 2003 Date of dealing 18 February 2003 Name of EMM Merrill Lynch International Name of offeree/offeror with whom connected Cambridge Antibody Tech Group Number of securities purchased Nil Highest price paid* n/a Lowest price paid* n/a Number of securities sold 8,050 Highest price paid* GBP 4.60 Lowest price paid* GBP 4.60 *Currency must be stated This information is provided by RNS The company news service from the London Stock Exchange END EMMNKCKDBBKDDBD
1 Year CAT Strategic Metals Chart |
1 Month CAT Strategic Metals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions